These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3797580)

  • 1. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey.
    Sato M
    Psychopharmacol Bull; 1986; 22(3):751-6. PubMed ID: 3797580
    [No Abstract]   [Full Text] [Related]  

  • 2. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic and clinical studies on methampetamine-related psychosis].
    Sato M
    Seishin Shinkeigaku Zasshi; 2002; 104(3):179-90. PubMed ID: 11985113
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on experimental models of methamphetamine-induced mental disorders--relationship between rat brain dopamine and changes in behavior].
    Koyama T; Ichikawa J; Nakayama M; Inoue T; Matsubara R
    Seishin Shinkeigaku Zasshi; 1988; 90(10):853-62. PubMed ID: 3251269
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder.
    Steiner W; Laporta M; Chouinard G
    Acta Psychiatr Scand; 1990 May; 81(5):437-40. PubMed ID: 1972608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
    Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
    Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis.
    Ohgake S; Hashimoto K; Shimizu E; Koizumi H; Okamura N; Koike K; Matsuzawa D; Sekine Y; Inada T; Ozaki N; Iwata N; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Shirayama Y; Iyo M
    Addict Biol; 2005 Jun; 10(2):145-8. PubMed ID: 16191666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis.
    Nakamura K; Sekine Y; Takei N; Iwata Y; Suzuki K; Anitha A; Inada T; Harano M; Komiyama T; Yamada M; Iwata N; Iyo M; Sora I; Ozaki N; Ujike H; Mori N
    Neurosci Lett; 2009 May; 455(2):120-3. PubMed ID: 19368859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on methamphetamine psychosis in a psychiatric clinic--comparison of acute and chronic-type cases].
    Teraoka A
    Seishin Shinkeigaku Zasshi; 1998; 100(7):425-68. PubMed ID: 9778996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ikemoto S; Goto K; Nishijima K; Kato S
    J Clin Psychopharmacol; 2003 Oct; 23(5):525-8. PubMed ID: 14520136
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 15. Supersensitivity psychosis with concurrent episodic vomiting.
    Malcolm K
    Br J Psychiatry; 1992 Sep; 161():407-9. PubMed ID: 1356574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

  • 17. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
    Kishimoto M; Ujike H; Motohashi Y; Tanaka Y; Okahisa Y; Kotaka T; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Biol Psychiatry; 2008 Jan; 63(2):191-6. PubMed ID: 17555717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thought disorder in amphetamine psychosis: a case report.
    Siomopoulos V
    Psychosomatics; 1976; 17(1):42-4. PubMed ID: 1273244
    [No Abstract]   [Full Text] [Related]  

  • 19. PET dopamine D2 receptors and susceptibility to methamphetamine psychosis.
    Iyo M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():652A-653A. PubMed ID: 1354071
    [No Abstract]   [Full Text] [Related]  

  • 20. A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis.
    Harano M; Uchimura N; Abe H; Ishibashi M; Iida N; Yanagimoto K; Tanaka T; Maeda H; Sora I; Iyo M; Komiyama T; Yamada M; Sekine Y; Inada T; Ozaki N; Ujike H
    Ann N Y Acad Sci; 2004 Oct; 1025():307-15. PubMed ID: 15542731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.